Parametric Portfolio Associates’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$518K Buy
20,863
+12,398
+146% +$320K ﹤0.01% 3084
2021
Q4
$271K Sell
8,465
-9,310
-52% -$340K ﹤0.01% 3312
2021
Q3
$640K Buy
17,775
+5,246
+42% +$206K ﹤0.01% 2995
2021
Q2
$553K Buy
12,529
+3,385
+37% +$147K ﹤0.01% 3042
2021
Q1
$418K Sell
9,144
-5,478
-37% -$314K ﹤0.01% 3577
2020
Q4
$1.01M Buy
+14,622
New +$716K ﹤0.01% 3048

Other funds holding LUNG

Parametric Portfolio Associates's LUNG Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Pulmonx (LUNG) stake by 146% in Q1 2022, buying an estimated $320K and bringing the position to 20,863 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

Parametric Portfolio Associates first reported a position in LUNG in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.01M in Q4 2020. 109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

  • Parametric Portfolio Associates held 20,863 shares of Pulmonx worth $518K as of Q1 2022.
  • Parametric Portfolio Associates bought 12,398 Pulmonx shares in Q1 2022, an estimated $320K.
  • Pulmonx made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3084 holding.
  • Parametric Portfolio Associates first reported a position in Pulmonx in Q4 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Pulmonx position peaked at $1.01M in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.